Maintaining vigilance for measles and acute paralytic poliomyelitis (polio) among arrivals from Afghanistan
Health alert
September 7, 2021
Select a tab below to navigate through sections:
Measles |
Acute Paralytic Poliomyelitis (Polio) |
---|---|
Consider measles infection in patients with compatible signs and symptoms, including:
|
Consider polio in patients with compatible signs and symptoms, including:
|
Assess patients with compatible signs and symptoms for:
|
Assess patients with compatible signs and symptoms for:
|
Instruct reception/triage staff to rapidly identify patients who present with compatible signs and symptoms of possible measles before or upon arrival:
|
Instruct hospital staff to rapidly identify patients who present with compatible signs and symptoms of possible polio and implement the following infection control precautions:
|
Collect specimens:
|
Collect specimens:
|
Route all laboratory specimens through Public Health to expedite testing, do not use a commercial laboratory. | |
Report suspected cases of measles or polio to Public Health at (206) 296-4774 immediately before discharging or transferring patients. |
In the setting of the Afghanistan evacuation, adults and children from Afghanistan are being resettled across the U.S.
Afghanistan ranks 7th in the world for measles cases and is one of only two countries with both wild type and vaccine-derived poliovirus in circulation. Afghanistan has low routine immunization coverage, including measles containing vaccine (MCV) and inactivated polio vaccine (IPV), and is reliant on frequent national and sub-national polio and measles vaccination campaigns to supplement the routine program.
All persons entering the U.S. with a humanitarian parolee status aged > 6months to 64 years (born in or before 1957) are required to receive one dose of measles, mumps, rubella (MMR) vaccine and those > 6 weeks of age are required to receive one dose of IPV.
Many persons arriving from Afghanistan will have their documents processed at military bases in the U.S. before traveling to their final destinations. The military bases will be providing these vaccinations free of charge.
However, if clinicians encounter arrivals from Afghanistan who do not have documentation of these vaccines, they should offer MMR and IPV vaccinations as follows:
- One dose of MMR vaccine for all aged >6 months to 64 years (born in or after 1957, and unless medically contraindicated), ideally within 7 days of U.S. entry. A first MMR dose between 6-11 months should be followed by the standard ACIP schedule [Birth-18 Years Immunization Schedule | CDC] with doses at 12-15 months and 4-6 years.
- One dose of IPV for all aged >6 weeks of age (including adults), ideally within 7 days of U.S. entry (unless medically contraindicated). This initial dose should be followed by the standard ACIP schedule with doses at 2, 4, and 6-18 months, and 4-6 years.
- Children who start the MMR or IPV series late can follow the catch-up immunization schedule [Catch-up Immunization Schedule | CDC].
- Arrivals with official documentation of measles and polio vaccination should continue the recommended ACIP routine or catch-up schedule.
This health advisory is also available in PDF format
- Pinkbook: Measles, CDC
- Pinkbook: Poliomyelitis, CDC
- Global Measles Outbreaks, CDC
- Acute Flaccid Myelitis, WA State Dept. of Health
- Measles fact sheet, Public Health - Seattle & King County